natgillin/translations-raw huggingface dataset:
30 film-coated tablets: EU/1/12/763/007 60 film-coated tablets: EU/1/12/763/008 120 film-coated tablets: EU/1/12/763/009
30 filmom obloženih tableta: EU/1/12/763/007 60 filmom obloženih tableta: EU/1/12/763/008 120 filmom obloženih tableta: EU/1/12/763/009
30 film-coated tablets: EU/1/12/763/013 60 film-coated tablets: EU/1/12/763/014 120 film-coated tablets: EU/1/12/763/015
30 filmom obloženih tableta: EU/1/12/763/013 60 filmom obloženih tableta: EU/1/12/763/014 120 filmom obloženih tableta: EU/1/12/763/015
30 G TUBE
TUBA OD 30 G
30 hard capsules.
30 tvrdih kapsula
30 June 2014
30. lipnja 2014.
30 kg and above
30 kg i više
30 mcg/0.3 ml
30 mcg/0,3 ml
30 mg
PVC/aluminij
30 mg (suspension or capsules) once weekly
30 mg (suspenzija ili kapsule) jednom tjedno
30 mg (suspension or capsules) single dose
30 mg (suspenzija ili kapsule) jednokratna doza
30 mg after each haemodialysis session
30 mg nakon svake hemodijalize
30 mg after every second haemodialysis session
30 mg nakon svake druge hemodijalize
30 mg dose
doza od 30 mg
30 mg emodepside, 150 mg praziquantel.
30 mg emodepsid, 150 mg prazikvantel.
30 mg hard gastro-resistant capsules
30 mg tvrde želučanootporne kapsule
30 mg once daily single dose3
30 mg jedanput na dan pojedinačna doza3
30 mg once weekly
30 mg jednom tjedno
30 mg oseltamivir suspension delivers 0.9 g of sorbitol.
30 mg oseltamivir suspenzije sadrži 0,9 g sorbitola.
30 mg single dose
30 mg jednokratna doza
30 mg single intravenous bolus plus a 1 mg/kg subcutaneous dose followed by 1 mg/kg once daily. (Maximum 100 mg for first subcutaneous dose only)
30 mg kao jednokratni intravenski bolus plus supkutana doza od 1 mg/kg nakon čega slijede doze od 1 mg/kg jedanput na dan. (Maksimalno 100 mg samo za prvu supkutanu dozu)
30 mg single intravenous bolus plus a 1 mg/kg subcutaneous dose followed by 1 mg/kg twice daily. (Maximum 100 mg for each of the first two subcutaneous doses)
30 mg kao jednokratni intravenski bolus plus supkutana doza od 1 mg/kg nakon čega slijede doze od 1 mg/kg dva puta na dan. (Maksimalno 100 mg za svaku od prve dvije supkutane doze)
30 mg tablet: blue, round (diameter: 8 mm), shallow-convex, debossed with “OTSUKA” and “30” on one side.
Tableta od 60 mg: plava, modificiranog pravokutnog oblika (dulja os 9,9 mm, kraća os 5,6 mm), blago konveksna, s utisnutim “OTSUKA” i “60” na jednoj strani.
30 mg tablet: blue, round (diameter: 8 mm), shallow-convex, debossed with “OTSUKA” and “30” on one side.
Tableta od 90 mg: plava, peterokutna (dulja os 9,7 mm, kraća os 9,5 mm), blago konveksna, s utisnutim “OTSUKA” i “90” na jednoj strani.
30 mg tablet: blue, round, with “OTSUKA” and “30” on one side.
Tableta od 30 mg: plava, okrugla, s utisnutim “OTSUKA” i “30” na jednoj strani.
30 mg twice daily
30 mg dva puta na dan
30 mg) once a day.
30 mg) jedanput dnevno.
30 mg) than that recommended in the treatment of MS.
30 mg) od one preporučene za liječenje multiple skleroze.
30 mg/50 mg Weekly
30 mg/50 mg tjedno
30 mg/50 mg Weekly + Metformin
tjedno + metformin
30 mg/kg twice daily
30 mg/kg dva puta na dan
30 mg: Round and pink, marked with "A" over "643" on one side and "30" on the other.
30 mg: Okrugla i ružičasta s oznakom "A" iznad "643" na jednoj strani i "30" na drugoj.
30 micrograms interferon beta-1a
30 mikrograma interferona beta-1a
30 micrograms PRE-FILLED SYRINGES LABEL
NALJEPNICA ZA NAPUNJENU ŠTRCALJKU 30 mikrograma
30 micrograms/0.3 ml solution for injection in pre-filled syringe 40 micrograms/0.3 ml solution for injection in pre-filled syringe 50 micrograms/0.3 ml solution for injection in pre-filled syringe 60 micrograms/0.3 ml solution for injection in pre-filled syringe 75 micrograms/0.3 ml solution for injection in pre-filled syringe 100 micrograms/0.3 ml solution for injection in pre-filled syringe 120 micrograms/0.3 ml solution for injection in pre-filled syringe 150 micrograms/0.3 ml solution for injection in pre-filled syringe 200 micrograms/0.3 ml solution for injection in pre-filled syringe 250 micrograms/0.3 ml solution for injection in pre-filled syringe 360 micrograms/0.6 ml solution for injection in pre-filled syringe
30 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 40 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 50 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 60 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 75 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 100 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 120 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 150 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 200 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 250 mikrograma/0,3 ml otopina za injekciju u napunjenoj štrcaljki 360 mikrograma/0,6 ml otopina za injekciju u napunjenoj štrcaljki
30 million IU
30 milijuna IU
30 million IU solution for injection in multidose pen 1 pen, 12 injection needles and 12 cleansing swabs 2 pens, 24 injection needles and 24 cleansing swabs 8 pens, 96 injection needles and 96 cleansing swabs
30 milijuna IU otopina za injekciju u višedoznoj brizgalici 1 brizgalica, 12 igala za injekciju i 12 tupfera za čišćenje 2 brizgalice, 24 igle za injekciju i 24 tupfera za čišćenje 8 brizgalica, 96 igala za injekciju i 96 tupfera za čišćenje
30 million IU/pen
30 milijuna IU/brizgalica
30 minutes of taking Eurartesim, the whole dose must be taken again.
30 minuta nakon uzimanja Eurartesima, mora se ponovno uzeti cijela doza.
30 ml bottle
30 ml bočica
30 ml bottle containing 30 Masivet 50 mg film-coated tablets.
Bočica od 30 ml sadrži 30 Masivet filmom obloženih tableta od 50 mg.
30 ml clear Type I glass vial with rubber stopper and aluminium cap with plastic seal.
Staklena bočica od 30 ml (prozirno staklo tipa I) s gumenim čepom i aluminijskom kapicom s plastičnim zaštitnim zatvaračem.
30 ml dose cup for measuring water
Čaša za doziranje od 30 ml za mjerenje vode
30 ml HDPE bottles with induction-sealed, polypropylene child-resistant caps; 20 film-coated tablets per bottle.
HDPE boce od 30 ml s polipropilenskim sigurnosnim zatvaračem za djecu sa zaštitnom folijom; 20 filmom obloženih tableta po boci.
30 ml of concentrate in a vial (Type I glass) with a stopper (butyl, siliconised), and a seal (aluminium) with flip-off cap (polypropylene).
30 ml koncentrata u bočici (staklo tipa I) s čepom (butil, silikonizirani) i zatvaračem (aluminij) s „flip- off“ kapicom (polipropilen).
30 mL of liquid should be administered as per the naso-gastric tube manufacturer’s instructions with appropriate water flushes.
Dobivenih 30 ml tekućine treba primijeniti u skladu s uputama proizvođača nazogastrične sonde, uz odgovarajuće ispiranje vodom.
30 ml plastic bottles capped with child-resistant induction seal closure; 20 film-coated tablets per bottle.
Plastičnim bocama od 30 ml zatvorenima sigurnosnim zatvaračem za djecu sa zaštitnom folijom; 20 filmom obloženih tableta po boci.
30 mL Type 1 glass vial with an elastomeric closure and an aluminium seal with a flip-off button containing 400 mg of siltuximab.
Bočica od stakla tipa I od 30 ml s elastomernim zatvaračem i aluminijskim “flip-off” zatvaračem koja sadrži 400 mg siltuksimaba.
30 mL Type 1 glass vial with an elastomeric stopper (butyl rubber with an inert polymer coating on the product contact surface and lubricant on the top surface for easier machinability) and aluminium seal with flip-off cap.
Bočica od stakla tipa 1 od 30 ml s elastomerskim čepom (od butilne gume s neaktivnom polimerskom prevlakom na dodirnoj površini sa lijekom te podmazivačem na vanjskoj površini čepa radi lakšeg rukovanja) te aluminijskim prstenom i „flip-off“ kapicom.
30 ml) once a day.
30 ml) jedanput dnevno.
30 ml: amber glass bottle (type III) with polypropylene child resistant closure, polyethylene insert and amber polypropylene dosing syringe.
30 ml: boca boje jantara (tip III) s polipropilenskim čepom za zaštitu od otvaranja za djecu, polietilenskim umetkom i polipropilenskom štrcaljkom za doziranje boje jantara.
30 patches
30 flastera
30 pouches
Transdermalni
30 pre-filled syringes
(staklena);
30 pre-filled syringes
EU/1/02/240/012
30 pre-filled syringes
napunjena
30 pre-filled syringes of solvent 30 injection needles
30 napunjenih štrcaljki s otapalom 30 igala za injekciju
30 prolonged-release hard capsules 30×1 prolonged-release hard capsules 50 prolonged-release hard capsules 50×1 prolonged-release hard capsules 100 prolonged-release hard capsules 1001 prolonged-release hard capsules
30 tvrdih kapsula s produljenim oslobađanjem 30×1 tvrdih kapsula s produljenim oslobađanjem 50 tvrdih kapsula s produljenim oslobađanjem 50×1 tvrdih kapsula s produljenim oslobađanjem 100 tvrdih kapsula s produljenim oslobađanjem 100x1 tvrdih kapsula s produljenim oslobađanjem
30 prolonged-release hard capsules 30×1 prolonged-release hard capsules 50 prolonged-release hard capsules 50×1 prolonged-release hard capsules 100 prolonged-release hard capsules 1001 prolonged-release hard capsules
30 tvrdih kapsula s produljenim oslobađanjem 30×1 tvrdih kapsula s produljenim oslobađanjem 50 tvrdih kapsula s produljenim oslobađanjem 50×1 tvrdih kapsula s produljenim oslobađanjem 100 tvrdih kapsula s produljenim oslobađanjem 10x1 tvrdih kapsula s produljenim oslobađanjem
30 prolonged-release tablets - EU/1/07/395/094 350 prolonged-release tablets - EU/1/07/395/095
30 tableta s produljenim oslobađanjem - EU/1/07/395/094 350 tableta s produljenim oslobađanjem - EU/1/07/395/095
30 sachets +
30 vrećica + 1 boca za miješanje +
30 sachets and 1 mixing bottle + 1 oral syringe
30 vrećica i 1 boca za miješanje + 1 štrcaljka za usta
30 sachets are packed in a carton together with 1 mixing cup and 2 oral dosing syringes.
U kutiji se nalazi 30 vrećica zajedno s 1 čašom za miješanje i 2 dozirne štrcaljke za usta.
30 sachets of 1 gram.
30 vrećica s 1 gramom.
30 sachets of powder for oral suspension
30 vrećica praška za oralnu suspenziju.
30 sachets per carton.
30 vrećica u kutiji.
30 sachets, powder for oral suspension in sachet 60 sachets, powder for oral suspension in sachet 90 sachets, powder for oral suspension in sachet
30 vrećica, prašak za oralnu suspenziju u vrećici 60 vrećica, prašak za oralnu suspenziju u vrećici 90 vrećica, prašak za oralnu suspenziju u vrećici
30 Sept 2016
30. rujna 2016.
30 September 2017
30. rujna 2017
30 single-dose containers
30 jednodoznih
30 single-dose containers
30 jednodoznih spremnika
30 soft capsules
30 mekih kapsula
30 sprays
30 potisaka
30 tablets
) 30 tableta
30 tablets
/PVC/alu
30 tablets
100 tableta
30 tablets
30 tablet
30 tablets
30 tableta.
30 tablets (PVC/PCTFE blisters)
30 tableta (PVC/PCTFE blisteri)
30 tablets 7 tablets
30 tableta 7 tableta
30 tablets bottle: 30 days
Bočica sa 30 tableta: 30 dana
30 tablets: EU/1/08/469/002
30 tableta: EU/1/08/469/002
30 tablets: EU/1/08/469/007
30 tableta: EU/1/08/469/007
30 tablets: EU/1/08/469/012
30 tableta: EU/1/08/469/012
30 tablets: EU/1/08/469/017
30 tableta: EU/1/08/469/017
30 tablets: EU/1/08/469/022
30 tableta: EU/1/08/469/022
30 tablets: EU/1/08/480/019
30 tableta: EU/1/08/480/019
30 tablets: EU/1/10/632/003
30 tableta: EU/1/10/632/003
30 tablets: EU/1/10/632/010
30 tableta: EU/1/10/632/010
30 tablets: EU/1/10/632/017
30 tableta: EU/1/10/632/017
30 tablets: EU/1/11/721/003
30 tableta: EU/1/11/721/003
30 tablets: EU/1/11/721/010
30 tableta: EU/1/11/721/010
30 tablets: EU/1/11/721/017
30 tableta: EU/1/11/721/017
30 tablets: EU/1/11/723/003
30 tableta: EU/1/11/723/003
30 tablets: EU/1/11/723/010
30 tableta: EU/1/11/723/010
30 tablets: EU/1/11/723/017
30 tableta: EU/1/11/723/017
30 to 40 kg
30 do 40 kg
30 to 49 ml/min
30 do 49 ml/min
30 to <40 kg
30 do <40 kg
30 to <40 kg
od 30 do <40 kg
30 to<50
30 do 50
30 to<50
30 do < 50
30 transdermal patches
30 transdermalnih flastera
30 TRANSLARNA 10 mg/kg, 10 mg/kg, 20 mg/kg (N=57)
TRANSLARNA 10, 10, 20 mg/kg (N=57)
30 unit doses
30 doza
30 vials +
(staklena)
30 vials +
30 bočica + 30
30 vials of powder
30 bočica s praškom
30 x (10 capsules +
30 x (10 kapsula +
30 x 1
30 x 1 tableta
30 x 1 (Unit dose)
30 x 1 (jedinična doza)
30 x 1 capsule (unit dose)
30 x 1 kapsula (jedinična doza)
30 x 1 capsules
30 x 1 kapsula
30 x 1 capsules (unit
30 x 1 kapsula
30 x 1 capsules (unit dose)
30 x 1 kapsula (jedinična doza)
30 x 1 chewable tablets
30 x 1 tableta za žvakanje
30 x 1 chewable tablets.
30 x 1 tableta za žvakanje
30 X 1 film-coated tablet
30 X 1 filmom obloženih tableta
30 x 1 film-coated tablet in white opaque PVC/PVdC-aluminium or aluminium-aluminium perforated unit-dose blisters.
30 x 1 filmom obložena tableta u bijelim, neprozirnim, PVC/PVdC-aluminijskim ili aluminij- aluminijskim perforiranim blisterima djeljivim na jedinične doze.
30 x 1 film-coated tablet; 3 blister cards of 10 x 1 film-coated tablet each in Alu/Alu perforated unit dose blisters, or
30 × 1 filmom obloženu tabletu; 3 blistera s 10 × 1 filmom obloženom tabletom, svaka u Al/Al perforiranim blisterima djeljivima na jedinične doze, ili
30 x 1 film-coated tablets
30 x 1 filmom obloženih tableta
30 x 1 hard gastro-resistant capsules
30 x 1 tvrdih želučanootpornih kapsula
30 x 1 soft capsules
30 x 1 mekih kapsula
30 x 1 soft capsules in Aluminium/aluminium perforated unit dose blisters
30 x 1 mekih kapsula u aluminij/aluminij perforiranim blisterima djeljivim na jedinične doze
30 x 1 tablet (unit dose)
30 x 1 tableta (jedinična doza)
30 x 1 tablets (unit
30 x 1 tableta
30 x 1 tablets (unit dose)
30 x 1 tableta (jedinična doza)
30 x 1 tablets (unit dose)
30 x 1 tableta (jedinične doze)
30 x 1 tablets (unit dose)
30 x 1 tableta (unit dose)
30 x 1 tablets (unit dose)
60 x 1 tableta
30 x 1 tablets in PVC/aluminium perforated unit dose blister.
30 x 1 tableta u PVC/aluminijskom perforiranom blisteru djeljivom na jedinične doze.
30 μg of ethinyloestradiol and
kontraceptiv sadrži najmanje 30
30 ≤ and < 50
30 ≤ i < 50
30% to 60% (IU/dl).
održavala na razini od 30% do 60
30, 50, 60, 100 and 200 tablets per pack.
100 i 200 tableta po pakiranju.
30, 60 or 90 sachets per carton.
30, 60 ili 90 vrećica po kutiji.
30-36 Avenue Gustave Eiffel 37100 Tours - France
30-36 Avenue Gustave Eiffel 37100 Tours - Francuska
30-36 Avenue Gustave Eiffel, BP 7166 F-37071 Tours Cedex 2 - France
30-36 Avenue Gustave Eiffel, BP 7166 F-37071 Tours Cedex 2 - Francuska
30-39 3.0 mg* zoledronic acid
30-39 3,0 mg* zoledronatne kiseline
30-45 minutes (ml/hr)
30-45 minuta (ml/sat)
30-49 ml/min) daily dose should be 10 mg per day.
30-49 ml/min), dnevna doza bi trebala biti 10 mg na dan.
30-60 Every 24 hours, at least 1 day, until healing is achieved.
30-60 Svaka 24 sata, najmanje 1 dan, do izlječenja.
30-60 Every 24 hours, at least 1 day,until healing is achieved
30-60 Svaka 24 sata tijekom najmanje 1 dana, do zacijeljenja.
30-60 Repeat infusion every 12-24 hours for 3-4 days or more until pain and acute disability are resolved
30-60 Ponavljati infuziju svakih 12-24 sata tijekom 3-4 dana ili dulje, do prestanka boli i akutne onesposobljenosti.
30-60 Repeat infusion every 12-24 hours for 3-4 days or more until pain and acute disability are resolved.
30-60 Ponoviti infuziju svakih 12-24 sata tijekom 3-4 dana ili više do prestanka bola i akutne onesposobljenosti.
30-90 mins
30 – 90 min
30-90 mins
30–90 min
30-day
30 dana
30-gauge needle alcohol wipes
30-G igla tupfer natopljen alkoholom
30-gauge needles for injecting your medicine
Igle veličine 30 G za injiciranje Vašeg lijeka
30-minute-value”), as described under steps 3 to 4.
Vrijeme uzorkovanja: 30-minutna vrijednost ”), kako je to opisano pod koracima 3 do 4.
30-minute-value”), as described under steps 3 to 4.
Vrijeme uzorkovanja: 30-minutna vrijednost”), kako je to opisano pod koracima 3 do 4.
30-Week Study
30-tjedno ispitivanje
30.1% (20.1; 40.0)c
118 (83,9; 153,4)c
30.2 (28.0, NR)
30,2 (28,0; ND)
30.7 to 32.5
30,7 do 32,5
30.7L/min p<0.001 (22.5, 38.9)
30,7 l/min p<0,001 (22,5; 38,9)
30/11/2015 (aligned with
30.11.2015. (ujednačeno s
300 (10 x 30) ampoules (multipack)
300 (10 x 30) ampula (višestruko pakiranje)
300 (10 x 30) AMPOULES WITH 2 ML
300 (10 x 30) AMPULA S 2 ML
300 (10x30) tablets (multipack)
300 (10x30) tableta (višestruko pakiranje)
300 (3 x 100 mg or 6 x 50 mg)
300 (3 x 100 mg ili 6 x 50 mg)
300 (6 x 50) tablets (multipack)
300 (6 x 50) tableta
300 ampoules
300 ampula
300 AMPOULES WITH 2 ML
300 AMPULA S 2 ML
300 ampoules.
300 ampula.
300 Capsules
300 kapsula
300 capsules
300 kapsule
300 copies/ml to
300 kopija/ml do
300 gastric adenocarcinoma patients (221 patients in the phase III part of the study and 79 patients in the phase II part) who received docetaxel in combination with cisplatin and 5-fluorouracil (clinically important treatment related adverse events are presented).
300 bolesnika s adenokarcinomom želuca (221 bolesnik u fazi III studije i 79 bolesnika u fazi II) koji su primali docetaksel u kombinaciji s cisplatinom i 5-fluorouracilom (prikazani su klinički značajni štetni događaji povezani s liječenjem),
300 IU/0.5 mL
Potkožno
300 IU/kg 3x/week for 4 weeks
300 IU/kg 3x/tjedno tijekom 4 tjedna
300 mcg/m2 intramuscularly (mcg/kg) (ml)
300 mikrograma/m2 intramuskularno (mcg/kg) (ml)
300 mg
pakiranje)
300 mg (30 ml) once daily
300 mg (30 ml) jedanput na dan
300 mg (30 ml) or 150 mg (15 ml)
300 mg (30 ml) ili 150 mg (15 ml)
300 mg (N = 156)
300 mg (N=156)
300 mg (N = 367)
300 mg (N=367)
300 mg (N = 587)
300 mg (N=587)
300 mg and ritonavir 100 mg (n=33)
300 mg s ritonavirom 100 mg (n=33)
300 mg at week 2; then 300 mg every 2 weeks
300 mg u 2. tjednu; potom 300 mg svaka 2 tjedna
300 mg at week 2; then 300 mg every 3 weeks
300 mg u 2. tjednu; potom 300 mg svaka 3 tjedna
300 mg dose - Use 3 vials (15 ml total, 5 ml per vial):
Doza od 300 mg – koristite 3 bočice (15 ml ukupno, 5 ml po bočici):
300 mg dose - Use 3 x 100 mg/5 ml vials (15 ml total, 5 ml per vial):
Doza od 300 mg – koristite 3 bočice x 100 mg/5 ml (15 ml ukupno, 5 ml po bočici):
300 mg film-coated tablets
300 mg filmom obložene tablete
300 mg once daily
20 mg jednom dnevno
300 mg once daily
300 mg jedanput
300 mg once daily
300 mg jedanput dnevno
300 mg once daily
300 mg jedanput na dan
300 mg once daily
Abakavir
300 mg once daily (Day 1 300 mg twice daily)*
300 mg jedanput na dan (1. dan 300 mg dvaput na dan)
300 mg once daily (given at the same time)
600/300 mg jedanput na dan
300 mg once daily thereafter (Part 1B and Part 2).
300 mg jedanput na dan (Dio 1B i Dio 2).
300 mg once daily.
300 mg jednom dnevno.
300 mg once daily.
jedanput na dan.
300 mg once daily†
300 mg jedanput dnevno
300 mg or
300 mg ili
300 mg powder for concentrate
300 mg prašak za koncentrat
300 mg prednisolone
300 mg prednizolon
300 mg prednisolone (9 g sachet)
300 mg prednizolon (9 g vrećica)
300 mg QD
300 mg 1x/dan
300 mg QD
CYP3A4]
300 mg QD (co-administered with voriconazole 350 mg BID)*
istodobno s vorikonazolom u dozi od 350 mg BID)
300 mg QD (co-administered with voriconazole 400 mg BID)*
300 mg QD (primijenjeno istodobno s vorikonazolom u dozi
300 mg QD (co-administered with voriconazole 400 mg BID)*
300 mg QD (primijenjeno istodobno s vorikonazolom u dozi od 400 mg BID)
300 mg QD (coadministered with voriconazole 350 mg BID)*
300 mg QD (primijenjeno
300 mg QD (coadministered with voriconazole 350 mg BID)*
300 mg QD (primijenjeno istodobno s vorikonazolom u dozi od 350 mg BID)
300 mg QD (coadministered with voriconazole 400 mg BID)*
300 mg QD (primijenjeno
300 mg QD (coadministered with voriconazole 400 mg BID)*
300 mg QD (primijenjeno istodobno s vorikonazolom u dozi od 400 mg BID)
300 mg QD (coadministered with voriconazole 400 mg BID)*
istodobno s vorikonazolom u dozi od 400 mg BID)
300 mg single dose
300 mg u jednoj dozi
300 mg single dose
ciklobenzap
300 mg single dose
prilagođavanje doze.
300 mg tablets and/or
mg i/ili 500 mg po jednoj
300 mg tablets:
Tablete od 300 mg:
300 mg TID (coadministered with voriconazole 400 mg
300 mg TID (primijenjeno istodobno s jednom dozom vorikonazola od 400 mg)
300 mg twice daily
300 mg dva puta
300 mg twice daily
300 mg dva puta na dan n=279
300 mg twice daily in newly diagnosed patients with CML in the chronic phase,
300 mg dva puta na dan u novodijagnosticiranih bolesnika s KML-om u kroničnoj fazi,
300 mg twice daily n=282 (%)
300 mg dva puta na dan n=282 (%)
300 mg vial
bočica od 300 mg
300 mg weekly x 1
300 mg tjedno x 1
300 mg) and proton-pump inhibitors has been reported to increase methotrexate levels in some patients.
300 mg) i inhibitora protonske pumpe prijavljen je porast razine metotreksata kod nekih bolesnika.
300 mg/ritonavir 100 mg once daily in
atazanavir 300 mg/ritonavir 100 mg
300 micrograms/m2 intramuscularly
300 mikrograma/m2 intramuskularno
300 micrograms/m2 intramuscularly (mcg/kg) (ml)
300 mikrograma/m2 intramuskularno (mcg/kg) (ml)
300 ml
AFTOVAXPUR DOE
300 ml [bottle label only]
300 ml [bočica]
300 ml amber glass bottle (type III) with a white child resistant closure (polypropylene) in a box also containing a 10 ml graduated oral dosing syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene).
Smeđa staklena boca od 300 ml (staklo tipa III) s bijelim zatvaračem sigurnim za djecu (polipropilen), u kutiji koja sadrži i graduiranu štrcaljku za usta od 10 ml (polipropilen, polietilen) te nastavak za štrcaljku (polietilen).
300 ml brown glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 10 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene).
Smeđa staklena boca od 300 ml (staklo tip III) s bijelim sigurnosnim zatvaračem za djecu (polipropilen) u kartonskoj kutiji koja također sadrži graduiranu štrcaljku za usta od 10 ml (polipropilen, polietilen) i nastavak za štrcaljku (polietilen).
300 ml brown glass bottle with a child-resistant closure, including a polyethylene sealing disc and a guarantee ring, a polypropylene dosing cup with embossed graduations from 5 to 30 ml in 5 ml increments, and a polypropylene oral syringe with graduations of 1 ml to 10 ml in 0.5 ml increments.
300 ml oralne otopine u smeđoj staklenoj bočici sa sigurnosnim zatvaračem za djecu, uključujući polietilnski zatvarač i sigurnosni prsten, polipropilensku dozirnu čašicu graduiranu od 5 ml do 30 ml (povećanja od 5 ml) i polipropilensku štrcaljka za usta graduiranu od 1 ml do 10 ml (povećanja od 0,5 ml).
300 ml oral solution
300 ml oralna otopina
300 ml oral solution
300 ml oralne otopine
300 tablets
300 tableta
300 to <500 cells/L
300 do <500 stanica/l
300 units/ml
300 jedinica/ml
300 µg.
300 µg. sintetički
300 µg. (a synthetic peptide analogue of GnRF conjugated to diphtheria toxoid)
300 µg. (sintetički analog peptida GnRF-a konjugiranog u difterijski toksoid)
300 μg. (a synthetic peptide analogue of GnRF conjugated to diphtheria toxoid)
300 μg. (sintetički analog peptida GnRF-a konjugiranog u difterijski toksoid)
300/100 mg once daily
300/100 mg jedanput
300/100 mg QD
300/100 mg 1x/dan 400/100 mg 1x/dan
3000 IU
EU/1/00/143/012
3000 IU (octocog alfa) (600 IU/mL after reconstitution).
3000 IU (oktokoga alfa) (600 IU/ml nakon pripreme za primjenu).
3000 IU moroctocog alfa for single IV use
3000 IU moroktokoga alfa za jednokratnu i.v. primjenu
3000 IU octocog alfa
3000 IU oktokoga alfa
3000 IU octocog alfa (600 IU/ml after reconstitution).
3000 IU oktokoga alfa (600 IU/ml nakon pripreme za primjenu).
3000 IU/0.3 ml
2000 IU/1,0 ml
3000 IU/0.3 ml
3000 IU/0,3 ml
3000 IU/0.5 ml
3 000 IU/0,5 ml
3000 mg/day
3000 mg/da n
3000 mg/day
3000 mg/dan
3000 µg/kg
3 000 µg/kg
30000 IU/0.75 ml
20000 IU/0,5 ml
30000 IU/0.75 ml
40000 IU/1 ml
30000 IU/1.0 ml
Eporatio
30000 Nîmes France
30000 Nîmes Francuska
300mg (6 sachetsa)
300mg (6 vrećicaa)
3014 Bern SWITZERLAND
3014 Bern ŠVICARSKA
305 74770 Opava-Komarov Czech Republic
305 74770 Opava-Komarov Češka Republika
305, 74770 Opava-Komarov Czech Republic
305, 74770 Opava-Komarov Češka
308 kcal/day to 476 kcal/day.
476 kcal/dan.
30938 Burgwedel GERMANY
30938 Burgwedel NJEMAČKA
30th June 2018
30. lipnja 2018.
30th June, 2019
30. lipnja 2019.
30x1 capsules + 1 inhaler.
30x1 kapsula + 1 inhalator.
30x1 film-coated tablets
30x1 filmom obloženih tableta
30x1 tablets (unit dose)
30x1 tableta (jedinična doza)